Cargando…

Dietary triglycerides profoundly affect oral sensitization to peanut protein in an adjuvant-free mouse model of peanut allergy

Detalles Bibliográficos
Autores principales:	Eckhardt, Erik, Li, Jianing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354091/ http://dx.doi.org/10.1186/2045-7022-1-S1-O33

Ejemplares similares

Effect of modification of peanut conglutin on IgE and T cell reactivity in adults with peanut allergy
por: van Hoffen, Els, et al.
Publicado: (2011)

Oral Peanut Challenge Identifies an Allergy but the Peanut Allergen Threshold Sensitivity Is Not Reproducible
por: Glaumann, Susanne, et al.
Publicado: (2013)

The individual role of peanut proteins Ara h1, 2, 3 and 6 in peanut allergy
por: Joost, Smit, et al.
Publicado: (2011)

Adjuvanted Immunotherapy Approaches for Peanut Allergy
por: Johnson-Weaver, Brandi T., et al.
Publicado: (2018)

Importance of Ara h 6 in peanut allergy diagnosis
por: Pedrosa, Maria, et al.
Publicado: (2014)

Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy
por: Brough, Helen A., et al.
Publicado: (2015)

Mouse strain differences in response to oral immunotherapy for peanut allergy
por: Wagenaar, Laura, et al.
Publicado: (2019)

Peanut Immunotherapy: Stepping Towards Desensitization for Peanut Allergy
por: Hsu, Joyce
Publicado: (2020)

Peanut Allergy: An Overview
por: Al-Ahmed, Nasser, et al.
Publicado: (2008)

Risk assessment of peanut protein traces found in refined peanut oil
por: Blom, Marty, et al.
Publicado: (2015)

Peanut allergy may be overdiagnosed in younger siblings of those with confirmed peanut allergy
por: Lavine, Elana, et al.
Publicado: (2014)

Oral immunotherapy for peanut allergy: The pro argument
por: Chinthrajah, R. Sharon, et al.
Publicado: (2020)

Oral immunotherapy for peanut allergy: The con argument
por: Fiocchi, Alessandro, et al.
Publicado: (2020)

Peanut allergy: Beyond the oral immunotherapy plateau
por: Bruton, Kelly, et al.
Publicado: (2021)

A novel peanut allergoid is safe and effective in immunotherapy in a peanut allergy mouse model
por: Smit, J, et al.
Publicado: (2013)

Role of Maternal Dietary Peanut Exposure in Development of Food Allergy and Oral Tolerance
por: Järvinen, Kirsi M., et al.
Publicado: (2015)

Developing Therapies for Peanut Allergy
por: Bublin, Merima, et al.
Publicado: (2014)

Secondary prevention of peanut allergy – continuous feeding or restriction of peanut protein
por: Bellach, J, et al.
Publicado: (2013)

Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy
por: Nilsson, Caroline, et al.
Publicado: (2011)

The Peanut Allergy Burden Study: Real-world impact of peanut allergy on resource utilization and productivity
por: McCann, William, et al.
Publicado: (2021)

T cell specific and non specific tolerance mechanisms in peanut oil immunotherapy in peanut allergic subjects
por: Singh, Amit, et al.
Publicado: (2011)

Are peanut oral food challenges still useful? An evaluation of children with suspected peanut allergy, sensitization to Ara h 2 and controlled asthma
por: Ojaniemi, Iida, et al.
Publicado: (2022)

Accidental exposures to peanut in a large cohort of Canadian children with peanut allergy
por: Cherkaoui, Sabrine, et al.
Publicado: (2015)

Long Non-Coding RNAs Expressed in the Peanut Allergy for Understanding the Pathophysiology of Peanut Allergy Rat Model
por: Liu, Manman, et al.
Publicado: (2022)

Adhesion molecules in experimental peanut allergy
por: Bennett, Jami, et al.
Publicado: (2010)

Is oral isotretinoin treatment contraindicated for patients with known peanut allergies?
por: Humphrey, Victoria S., et al.
Publicado: (2020)

Peanut thresholds in peanut‐allergic children are related to dietary composition
por: Luiten, Daisy, et al.
Publicado: (2023)

sIgE to peanut components does not accurately predict the severity of allergy in subjects suspected of peanut allergy
por: Klemans, Rob, et al.
Publicado: (2015)

Accidental exposure (AE) to peanut in a large cohort of Canadian children with peanut allergy
por: Cherkaoui, Sabrine, et al.
Publicado: (2014)

Peanut allergy: Effect of environmental peanut exposure in children with filaggrin loss-of-function mutations
por: Brough, Helen A., et al.
Publicado: (2014)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants
por: Fleischer, David M., et al.
Publicado: (2015)

Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States
por: Blaiss, Michael S, et al.
Publicado: (2021)

Measurement of IgE antibodies to minor components in eosinophilic esophagitis, peanut allergy, and delayed anaphylaxis to mammalian meat
por: Tripathi, Anubha, et al.
Publicado: (2014)

Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status
por: Asai, Yuka, et al.
Publicado: (2013)

Allergy to Peanuts imPacting Emotions And Life (APPEAL): the impact of peanut allergy on children, adolescents, adults and caregivers in France
por: Couratier, Pascale, et al.
Publicado: (2020)

Diagnosis of Peanut Allergy in Preschool Children: The Impact of Skin Testing With a Novel Composition of Peanuts
por: Kidon, Mona I., et al.
Publicado: (2021)

Antenatal risk factors for peanut allergy in children
por: Binkley, Karen E, et al.
Publicado: (2011)

Peanut, soy, and emerging legume allergy in Canada
por: Cosyns, Josie C.E., et al.
Publicado: (2022)

Safety of isotreinoin treatment in peanut and soy allergy
por: Zurlo, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t7booterqtl9h7j1bcv1j3iqdg